62848-20-8

Basic information

• Product Name: 3-METHOXYPYRROLIDINE
• Synonyms: 3-METHOXYPYRROLIDINE;3-Methoxypyrrolidine hydr...;Pyrrolidine, 3-methoxy-
• CAS NO: 62848-20-8
• Molecular Formula: C₅H₁₁NO
• Molecular Weight: 101.15
• Mol File: 62848-20-8.mol

Chemical Properties

• Boiling Point: 122.9 °C at 760 mmHg
• Flash Point: 35.2 °C
• Appearance: /
• Density: 0.94 g/cm³
• Vapor Pressure: 13.6mmHg at 25°C
• Refractive Index: 1.445
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 3-METHOXYPYRROLIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-METHOXYPYRROLIDINE(62848-20-8)
• EPA Substance Registry System: 3-METHOXYPYRROLIDINE(62848-20-8)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 62848-20-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Methoxypyrrolidine is used as a chiral intermediate for the synthesis of various medicinal products. Its unique properties allow for the creation of enantiomerically pure compounds, which are essential in the development of effective and safe drugs.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Methoxypyrrolidine serves as a key building block in the synthesis of a range of agrochemicals. Its ability to act as a chiral intermediate contributes to the development of more targeted and environmentally friendly pesticides and other agricultural chemicals.
Used as a Solvent in Chemical Reactions:
3-Methoxypyrrolidine is utilized as a solvent in various chemical processes due to its compatibility with a wide range of substances and its ability to facilitate specific types of reactions, enhancing the efficiency and selectivity of these processes.
Used as an Additive in Consumer Products:
3-Methoxypyrrolidine also finds application as an additive in some consumer products, where it may contribute to the product's performance or stability, leveraging its versatile chemical properties to meet specific requirements in various consumer markets.

InChI:InChI=1/C5H11NO/c1-7-5-2-3-6-4-5/h5-6H,2-4H2,1H3

Upstream product

• 146257-03-6 3-Methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 136725-50-3 (+/-)-3-methoxypyrrolidine hydrochloride 

Downstream Products

• 947499-05-0 1-(3-bromophenyl)-3-methoxypyrrolidine 

Relevant articles and documents

2-SUBSTITUTED-ETHYNYLTHIAZOLE DERIVATIVES AND USES OF SAME

The present invention provides 2-substituted-ethynylthiazole derivatives of formula (I): wherein R1, R2 and X are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods of using same.

NEW BRADYKININ B1 ANTAGONISTS

The invention relates to compounds of formula (I) where in R1, R1a, R1b, R2, R3 and X, X1, X2, X3 have the meaning as cited in the description and the claims. Said compounds are useful as Bradykinin B1 antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.

1 H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of -disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.